Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System
Preprint, not peer reviewed. Krantz MJ, Haigney MC, Southworth MR et al.. medRxiv, 10 Sep 2026.
Tags: Preprint, Psilocybin, MDMA, LSD, DMT, Ibogaine, Mescaline, Addiction.
FDA adverse event analysis claims an arrhythmia signal across psychoactive Schedule I substances and kratom; disproportionality data, not incidence
How much weight it carries: Not peer reviewed. Early results that may not hold up. (Preprint)
Read the original